Elexure Formulations Private Limited
About Elexure Formulations Private Limited
Data last updated:
Elexure Formulations Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It was incorporated on 16 March 2023.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U47721TN2023PTC158912.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Seeniammal (Managing Director) and Muthusamy Buvaneshwaran.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Chennai, Tamil Nadu.
As per the financials filed for FY 2025, the company reported a revenue of ₹38.26 Lakh, a growth of 131% compared to the previous year. For the same year it recorded a net loss of ₹42.29 Lakh (net margin -110.5%) and EBITDA of -₹41.54 Lakh (EBITDA margin -108.6%).
Company details
Contact details
Elexure Formulations Private Limited's registered office is in Chennai, Tamil Nadu.
- Registered AddressNo. 35, Murugappa Reddy Street Venkatapuram, Chennai, Tamil Nadu, India – 600053
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Elexure Formulations is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Elexure Formulations Private Limited, buy the company report.
Financials of Elexure Formulations Private Limited
FY 2025 filings availableElexure Formulations Private Limited reported revenue of ₹38.26 Lakh (up 131% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 131% in the latest year. EBITDA fell 100% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹41.54 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹42.29 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -108.6% | ||
| Net Profit Margin | -110.5% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Elexure Formulations Private Limited, buy the company report.
Board of directors of Elexure Formulations Private Limited
Elexure Formulations has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Seeniammal | Managing Director | 16 Mar 2023 | 3 Years 7 Months | Current |
| Muthusamy Buvaneshwaran | Director | 16 Mar 2023 | 3 Years 7 Months | Current |
Peer comparison
Elexure Formulations Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Godwit Formulations Private Limited | ₹38.48 Lakh (FY 2020) | 58.0% | New Delhi, Delhi, India | |||
| Alverstone Drug House Private Limited | ₹38.46 Lakh (FY 2025) | 125.0% | Thiruvananthapuram, Kerala, India | |||
| Kashyap Pharmaceuticals Private Limited | ₹38.44 Lakh (FY 2024) | 86.0% | Thane, Maharashtra, India | |||
| Strainth India Private Limited | ₹38.39 Lakh (FY 2023) | 65.0% | Lucknow, Uttar Pradesh, India | |||
| Elexure Formulations Private Limitedthis company | ₹38.26 Lakh (FY 2025) | -₹42.29 Lakh | -110.5% | 131.0% | Chennai, Tamil Nadu, India | |
| Emrick Pharmaceuticals Private Limited | ₹38.25 Lakh (FY 2025) | -18.0% | Bulandshahr, Uttar Pradesh, India | |||
| Rabina and Raj Impex (OPC) Private Limited | ₹38.23 Lakh (FY 2021) | Kolkata, West Bengal, India | ||||
| Katharine Pharmaceuticals Private Limited | ₹38.1 Lakh (FY 2025) | 45.0% | Jaipur, Rajasthan, India | |||
| Eton Biotech Private Limited | ₹38.09 Lakh (FY 2022) | Ambala, Haryana, India |
To see the full peer comparison of Elexure Formulations Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Elexure Formulations Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Elexure Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Elexure Formulations Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Elexure Formulations Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Muthusamy Buvaneshwaran was appointed as Director on 16 Mar 2023.
Frequently asked questions
Elexure Formulations is an active private limited company based in Chennai, Tamil Nadu, India. It was incorporated on 16 March 2023 (3+ years old) and is registered under CIN U47721TN2023PTC158912.
Elexure Formulations has 2 current directors:
- Seeniammal - Managing Director
- Muthusamy Buvaneshwaran - Director
The latest financial statements of Elexure Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Elexure Formulations is U47721TN2023PTC158912. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Elexure Formulations was incorporated on 16 March 2023, making it 3+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Elexure Formulations by revenue are Godwit Formulations Private Limited, Alverstone Drug House Private Limited, Kashyap Pharmaceuticals Private Limited, Strainth India Private Limited, Emrick Pharmaceuticals Private Limited and 3 more, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Muthusamy Buvaneshwaran was appointed as Director on 16 Mar 2023. Seeniammal was appointed as Managing Director on 16 Mar 2023.
The registered office of Elexure Formulations is at No. 35, Murugappa Reddy Street Venkatapuram, Chennai, Tamil Nadu, India – 600053.
Elexure Formulations can be reached at its registered office: No. 35, Murugappa Reddy Street Venkatapuram, Chennai, Tamil Nadu, India – 600053.
Elexure Formulations is registered under the jurisdiction of the Registrar of Companies (ROC), Chennai.